Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer79

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer43

Views

Views
July 202524
August 20250
September 20252
October 20252
November 20259
December 20256
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil17
United States12
United Kingdom4
Germany2
Argentina1
Colombia1
Egypt1
Ethiopia1
Kenya1
Nicaragua1
 

Top cities views

Views
Rio de Janeiro2
Frankfurt am Main2
Addis Ababa1
Ashburn1
Avaré1
Bugalagrande1
Chicago1
Durban1
Foz do Iguaçu1
Giza1